Effectiveness of deferiprone in transfusionindependent beta-thalassemia/HbE patients
Beta-thalassemia/HbE (beta-thal/HbE) is a thalassemia intermedia (TI) which encompasses a broad spectrum of severity. Here, we used deferiprone (DFP) as an iron chelating agent in TI patients receiving intermittent blood transfusion who are asymptomatic for cardiovascular disease in order to evaluat...
Saved in:
Main Authors: | Krittapoom Akrawinthawong, Nithima Chaowalit, Thanasaporn Chatuparisuth, Noppadol Siritanaratkul |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/12592 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
by: Tran N.T.
Published: (2023) -
Glutathione Redox system in Beta-Thalassemia/Hb E patients
by: Kalpravidh, Ruchaneekorn W., et al.
Published: (2015) -
Iron metabolism in heterozygotes for hemoglobin E (HbE), α-thalassemia 1, or β-thalassemia and in compound heterozygotes for HbE/β-thalassemia
by: Michael B. Zimmermann, et al.
Published: (2018) -
Accelerated telomere shortening in β-thalassemia/HbE patients
by: Pornthip Chaichompoo, et al.
Published: (2018) -
Hemoglobin levels and red blood cell indices in mid-gestational fetuses with beta-thalassemia/HbE, beta-thalassemia trait or Hb E trait and normal fetuses
by: Kasemsri Srisupundit, et al.
Published: (2018)